Skip to content
by Legal Desire
Jurisdiction

Nasdaq

11 announced deals involving Nasdaq, most recent first, with the firms that advised on each.

Most recent

SEARCH ALL 11
DLA Piper guides First Digital through De-SPAC business combination with KOYN 19 Oct 2026
Capital Markets & IPO Technology DLA Piper 11 NAMED
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio 24 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 230m 29 NAMED
Latham & Watkins Advises on newcleo’s Business Combination With NewHold Investment Corp III to Become Public Company 31 May 2026
Capital Markets & IPO Energy Latham & Watkins LLP 5 NAMED
Norton Rose Fulbright advises Nauticus Robotics on series of capital financings 26 Dec 2024
Capital Markets & IPO Technology Norton Rose Fulbright USD 21m 5 NAMED
Latham & Watkins Advises Leading Biomaterials Company Bolt Threads, Inc. in Definitive Business Combination Agreement With Golden Arrow Merger Corp. 7 Oct 2023
M&A Latham & Watkins LLP USD 35m 23 NAMED
Latham & Watkins Represents Tempo Automation in Merger With ACE Convergence Acquisition Corp. 30 Nov 2022
M&A Latham & Watkins LLP 17 NAMED
Sidley Represents Bridger Aerospace in Business Combination with SPAC Jack Creek Investment Corp. 4 Aug 2022
M&A Aerospace & Defence Sidley USD 869m 30 NAMED
Freshfields Advises Zymergen on its Sale to Ginkgo Bioworks — First-Ever Sale of a Publicly-Listed Public Benefit Corporation 25 Jul 2022
M&A Healthcare & Life Sciences Freshfields USD 300m 30 NAMED
DLA Piper advises Lionheart Acquisition Corp. II in US$32.6 billion SPAC deal with MSP Recovery 14 Jul 2021
M&A Healthcare & Life Sciences DLA Piper USD 32.6bn 9 NAMED
Latham & Watkins Advises on Monday.com IPO 11 Jun 2021
Capital Markets & IPO Technology Latham & Watkins LLP 26 NAMED
Latham & Watkins Advises Placement Agents in PIPE in Connection with Roivant Sciences and Montes Archimedes Acquisition Corp. Combination 4 May 2021
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 200m 6 NAMED